Chemistry, Manufacturing and Controls and Related Services for Development of Drug Products
Award Notice Posted
- Solicitation number
- 75N95025R00005
- Agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Awarded
- to Sri International
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75N95026D00004 Federal IDV award
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Place of performance
- Frederick, Maryland 21703, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institute of Allergy and Infectious Diseases awarded a competitive multiple-award IDIQ contract to Eminent Services Corp for chemistry, manufacturing and controls and related services for development of drug products, with the award made on July 1, 2026.
The ordering period runs from July 1, 2026 through July 31, 2031. Task orders issued against this contract will most likely be cost-reimbursement, term/completion type; the Government anticipates fixed-price task orders are generally not feasible due to absence of precise specifications and difficulties in cost estimation, given the dynamic, science-responsive, and result-driven nature of the work. Fixed-price task orders may be issued where appropriate and feasible. The contractor is eligible for task orders under Technical Area 1. The award followed unrestricted competition and was not made under a set-aside category.
Notice text
A competitive multiple award, Indefinite Delivery/Indefinite Quantity (ID/IQ) type contract was awarded, with a ordering period (July 1, 2026 through July 31, 2031). It is anticipated that Task Orders issued against these contracts will most likely be cost-reimbursement, term/completion type Task Orders. Upon analysis of the type of work and all associated costs involved, fixed-price type task orders are usually not feasible due to the absence of precise specifications and difficulties in estimating costs with accuracy. Based upon the uncertainties involved, the Government would assume undue risk in attempting to fit relatively dynamic (science responsive and result-drive) requirement into a fixed-price environment. In these instances, fixed-price task orders would be disadvantageous to the Government, since they do not provide the Government with the flexibility that is needed to reasonably and responsively shift with the evolving needs of this requirement. However, fixed price Task Order may be issued, where appropriate and feasible.
The Contractor is eligible for Task Orders under Technical Area 1.
The award notice is in relation to Solicitation # 75N95025R00005.
Awarded contract 75N95026D00004 to EMINENT SERVICES CORP for 49885703.00 on 2026-07-01.
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Award Notice | |
| Chemistry, Manufacturing and Controls and Related Services for Development of Drug Products | Award Notice | |
| Chemistry, Manufacturing and Controls and Related Services for Development of Drug Products | Award Notice | |
| Chemistry, Manufacturing and Controls and Related Services for Development of Drug Products | Award Notice | |
| Chemistry, Manufacturing and Controls and Related Services for Development of Drug Products | Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Pre-Clinical Models of Infectious Diseases | National Institute of Allergy and Infectious Diseases | No set-aside | |
| 2027 NIAID DMID Omnibus Broad Agency Announcement: Development of Medical Interventions for Infectious Diseases | National Institute of Allergy and Infectious Diseases | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity